$MMED

4 stories mentioning MMEDUpdated just now

Every FINWIRES story that references MMED, newest first.

MiniMed Launches Flex Insulin Pump in US

MiniMed (MMED) launched its Flex insulin pump system in the US, the company said Wednesday.The system is cleared by the US Food and Drug Administration for people aged 7 and older with type 1 diabetes and adults with insulin-requiring type 2 diabetes, MiniMed said.The Flex system is the company's first app-controlled insulin pump and is paired at launch with the Simplera Sync, a disposable continuous glucose monitoring sensor, the company said.Price: $15.14, Change: $+0.44, Percent Change: +2.99%

$MMED

Sectors14d ago

Sector Update: Healthcare Stocks Mixed Premarket Wednesday

Healthcare stocks were mixed premarket Wednesday, with the iShares Biotechnology ETF (IBB) down 0.1% and the State Street Health Care Select Sector SPDR ETF (XLV) marginally higher.Medtronic (MDT) shares were up more than 5% after the company reported fiscal Q4 adjusted earnings and revenue that topped analysts' expectations.MiniMed (MMED) stock was up more than 4% after the company posted higher fiscal Q4 revenue.TG Therapeutics' (TGTX) subcutaneous formulation of ublituximab showed "positive" pharmacokinetic, pharmacodynamic, safety, and tolerability data from a phase 1 clinical trial comparing the multiple sclerosis therapy to the drug's intravenous version, the company said.Shares of TG Therapeutics were up more than 5% pre-bell.

$IBB$MDT$MMED$TGTX$XLV

Research36d ago

Benchmark Initiates MiniMed Group at Buy

MiniMed Group, Inc. (MMED) has an average rating of buy and mean price target of $22.25, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$MMED

Wire50d ago

MiniMed Receives Health Canada License for 780G System Software

MiniMed Group (MMED) said Tuesday that Health Canada has licensed new software for its MiniMed 780G system in Canada.With the authorization, the MiniMed 780G system now offers greater flexibility, combining Meal Detection technology and SmartGuard with both the Guardian 4 and Simplera Sync sensors.Simplera Sync is a disposable, all-in-one sensor that requires no fingersticks with SmartGuard, no overtape, and features a two-step insertion process. The MiniMed 780G system is also now compatible with Fiasp and indicated for adults aged 18 and older with Type 2 diabetes.The Simplera Sync sensor will be available in Canada later this year, the company said.Price: $12.91, Change: $-0.02, Percent Change: -0.12%

$MMED

Track with the FINWIRES app suite

FolioX

Track MMED in your portfolio

WheelAI

Analyze MMED options with the wheel strategy

StockInsider

See market sentiment on MMED